Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
In this study we analyzed the expression of four hepatic progenitor cell markers in 251 hepatocellular carcinomas (HCCs) with their clinical data and tumor markers, and significance of the hepatic progenitor markers in HCC for prognosis. We elucidated that EpCAM expression, DCP>300 mAU/ml, age > 60, Child-Pugh sore grade B or C were independent prognostic factors of poor outcome and were used in a new scoring system for HCC prognosis after operation. Expression of two or more HPC markers was a significant predictor of poor HCC outcome and co-related with AFP and AFP-L3 levels, blood vessel invasion and differentiation of the tumor.
|